首页 > 市场调查报告书 > 医疗设备

心血管设备

心臟帮浦设备市场规模、份额和成长分析（按产品、应用、最终用户和地区）：产业预测（2025-2032）

市场调查报告书

商品编码

1796411

心臟帮浦设备市场规模、份额和成长分析（按产品、应用、最终用户和地区）：产业预测（2025-2032）

Heart Pump Device Market Size, Share, and Growth Analysis, By Product (Ventricular Assist Devices, Intra-Aortic Balloon Pumps ), By Application (Bridge-to-Transplant, Destination Therapy ), By End User, By Region - Industry Forecast 2025-2032

出版日期: 2025年08月19日 | 出版商:

SkyQuest | 英文 192 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计 2023 年全球心臟帮浦设备市场价值将达到 22 亿美元，并从 2024 年的 25.8 亿美元成长到 2032 年的 93.2 亿美元，预测期内（2025-2032 年）的复合年增长率为 17.4%。

全球心臟泵设备市场正经历强劲成长，这得益于技术进步、人口老化和心血管疾病发病率上升。世界各国政府将加强医疗基础设施和整合尖端医疗技术作为优先事项，旨在优化患者治疗效果和管理慢性心臟疾病。市场正在见证增强技术能力的重大创新，例如机器学习和人工智慧的融合。这些进步正在改变患者资料管理，促进根据个别患者状况、活动量和生理反应对设备进行超个人化、即时调整，从而推动改善治疗效果和患者照护。不断变化的情况凸显了心臟帮浦技术持续进步的潜力。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争格局

前五大公司对比
主要企业的市场定位（2024年）
主要企业采取的策略
近期市场趋势
主要企业市场占有率（2024年）
主要企业简介
- 公司简介
- 产品系列分析
- 按细分市场分析市场份额
- 收益同比对比（2022-2024 年）

主要企业简介

ABIOMED
BiVACOR Inc.
Berlin Heart
CARMAT
CorWave SA
Evaheart, Inc.
Fresenius SE & Co. KGaA
Getinge AB
Jarvik Heart
Leviticus Cardio
LivaNova PLC
Medtronic plc
SynCardia Systems, LLC
Teleflex Incorporated

结论和建议

简介目录

Product Code: SQMIG35A2376

Global Heart Pump Devices Market size was valued at USD 2.2 billion in 2023 and is poised to grow from USD 2.58 billion in 2024 to USD 9.32 billion by 2032, growing at a CAGR of 17.4% during the forecast period (2025-2032).

The global Heart Pump Devices market is experiencing robust growth driven by an aging demographic and increasing rates of cardiovascular diseases alongside ongoing technological advancements. Governments worldwide are prioritizing enhancements in healthcare infrastructure and the integration of cutting-edge medical technologies aimed at optimizing patient outcomes and managing chronic heart conditions. This market has been marked by significant innovations that enhance technological capabilities, including the convergence of machine learning and artificial intelligence. These advancements have transformed the management of patient data, facilitating hyper-personalized real-time adjustments to devices based on individual patient conditions, activity levels, and physiological responses, thereby promoting improved treatment efficacy and patient care. The evolving landscape underscores the potential for continued progress in heart pump technologies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Heart Pump Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Heart Pump Devices Market Segments Analysis

Global Heart Pump Devices Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Ventricular Assist Devices (VADs), Intra-Aortic Balloon Pumps (IABPs) and Total Artificial Hearts (TAHs). Based on Application, the market is segmented into Bridge-to-Transplant (BTT), Destination Therapy (DT) and Bridge-to-Recovery (BTR). Based on End User, the market is segmented into Hospitals, Cardiac Centers and Ambulatory Surgical Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Heart Pump Devices Market

A significant catalyst for the expansion of the heart pump devices sector is the growing incidence of advanced heart failure among patients. With the limited availability of heart transplants, the role of mechanical circulatory support has become increasingly vital for patient survival. As healthcare facilities increasingly adopt long-term solutions such as Left Ventricular Assist Devices (LVADs) and Total Artificial Hearts (TAHs) as essential life-saving interventions, the surge in critical cardiac conditions bolsters the demand for heart pump devices. This trend underscores the necessity for innovative solutions in managing severe heart ailments, ultimately driving market growth and evolution in this field.

Restraints in the Global Heart Pump Devices Market

The Global Heart Pump Devices market faces significant challenges due to the high costs associated with implantation and the subsequent post-operative care, despite the clinical benefits. This situation is particularly pronounced in low- and middle-income countries, where the financial burden of these procedures often exceeds the capabilities of healthcare systems and patients. Furthermore, the market penetration is restricted, as access to these advanced devices is predominantly available in well-equipped hospitals and regions with established insurance frameworks or reimbursement policies. These economic barriers limit the widespread adoption and usage of heart pump technologies, thereby inhibiting market growth.

Market Trends of the Global Heart Pump Devices Market

The Global Heart Pump Devices market is witnessing a prominent trend toward minimally invasive implantation techniques, driven by their ability to enhance patient outcomes and streamline procedural efficiency. As healthcare providers prioritize shorter recovery times and reduced hospital stays, there is an increasing demand for smaller, user-friendly devices designed for less invasive procedures. This shift is prompting manufacturers to innovate and refine their product offerings, focusing on advanced technologies that facilitate smoother implantation processes. Consequently, the market is evolving to meet these demands, reflecting a broader industry commitment to improving cardiovascular care through enhanced surgical approaches.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technology Analysis
Case Studies
Customer Buying Behavior Analysis

Global Heart Pump Devices Market Size by Product & CAGR (2025-2032)

Market Overview
Ventricular Assist Devices (VADs)
Intra-Aortic Balloon Pumps (IABPs)
Total Artificial Hearts (TAHs)

Global Heart Pump Devices Market Size by Application & CAGR (2025-2032)

Market Overview
Bridge-to-Transplant (BTT)
Destination Therapy (DT)
Bridge-to-Recovery (BTR)

Global Heart Pump Devices Market Size by End User & CAGR (2025-2032)

Market Overview
Hospitals
Cardiac Centers
Ambulatory Surgical Centers

Global Heart Pump Devices Market Size & CAGR (2025-2032)

North America (Product, Application, End User)
- US
- Canada
Europe (Product, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

ABIOMED
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BiVACOR Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Berlin Heart
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CARMAT
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CorWave SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Evaheart, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius SE & Co. KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Getinge AB
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jarvik Heart
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Leviticus Cardio
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SynCardia Systems, LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teleflex Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments